Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.

CONCLUSION: CLAG was effective and well tolerated for R/R AML. BM blasts ≥42.1%, age ≥60 years, high risk stratification, and second or higher salvage therapy were independent factors for a poor prognosis.
PMID: 30517910 [PubMed - as supplied by publisher]

Source: Acta Haematologica - December 5, 2018 Category: Hematology Authors: Wang L, Xu J, Tian X, Lv T, Yuan G Tags: Acta Haematol Source Type: research